Chatmongkonwat Tanet, Phool Wongpipat, Ruengwongroj Patchara, Khiewcharoen Naddakan, Aroonasirakul Pornchai, KittiJaroenwong Vatchara, Lukkraisorn Satit, Napaaumpaiporn Rungarun
Departments ofSurgery.
Rehabilitation, Chiangrai Prachanukroh Hospital, Chiangrai, Thailand.
Ann Med Surg (Lond). 2023 Nov 17;86(1):69-72. doi: 10.1097/MS9.0000000000001481. eCollection 2024 Jan.
Tumour size appear to be a risk factor of axillary lymph node metastasis in breast cancer. Recent evidence shows that higher the T staging is associated with higher rate of axillary lymph node metastasis. However, no studies shows that in the same T staging or tumour size but different breast size or breast volume the incidence of axillary lymph node metastasis differ or not .
This Study aimed to investigate the association between tumour to breast ratio in breast cancer as a predictive factor of axillary lymph node metastasis.
This study included 200 consecutive patients diagnosed with breast cancer between January 2012 to march 2022. The authors retrospectively reviewed medical data pathologic report and Ultrasonography and mammography of breast. Tumour diameter reported in pathologic report was used to calculate tumour volume using formula for ellipse. Breast volume was calculate using formula referencing from study of all by formula Breast Volume=1/3×¶×Radiusccview×Heightccview by measuring from mammography of patient. Tumour volume to breast volume ratio was calculated and analyzed.
Of 200 patient included in this study, 84 patient (42%) was in lymph node positive group and 116 patient (58%) was in lymph node-negative group. Median for tumour and breast volume ratio in node positive group was higher [median 0.0093 (interquartile range=0.0047-0.023)] than in node-negative group [median 0.0065 (interquartile range (0.0028-0.0199)]. =0.0414 receiver operating characteristic curve for tumour to breast ratio showed AUC of 0.7389 (95% CI 0.67993-0.82335) Which seems to be a significance as predictive factors for Axillary lymph node metastasis.
Higher tumour volume to breast volume ratio tends to be a significance predictive factors for axillary lymph node metastasis in breast cancer patients.
肿瘤大小似乎是乳腺癌腋窝淋巴结转移的一个风险因素。最近的证据表明,T分期越高,腋窝淋巴结转移率越高。然而,尚无研究表明在相同的T分期或肿瘤大小但不同的乳房大小或乳房体积情况下,腋窝淋巴结转移的发生率是否存在差异。
本研究旨在探讨乳腺癌中肿瘤与乳房的比例作为腋窝淋巴结转移预测因素之间的关联。
本研究纳入了2012年1月至2022年3月期间连续诊断为乳腺癌的200例患者。作者回顾性分析了患者的医疗数据、病理报告以及乳房超声和乳腺X线摄影检查结果。病理报告中报告的肿瘤直径用于使用椭圆公式计算肿瘤体积。乳房体积通过参考一项研究中的公式计算,该公式为乳房体积=1/3×π×半径ccview×高度ccview,通过测量患者的乳腺X线摄影图像获得。计算并分析肿瘤体积与乳房体积之比。
本研究纳入的200例患者中,84例(42%)为淋巴结阳性组,116例(58%)为淋巴结阴性组。淋巴结阳性组的肿瘤与乳房体积比中位数[中位数0.0093(四分位间距=0.0047 - 0.023)]高于淋巴结阴性组[中位数0.0065(四分位间距(0.0028 - 0.0199)]。肿瘤与乳房体积比的受试者工作特征曲线显示曲线下面积为0.7389(95%可信区间0.67993 - 0.82335),这似乎具有作为腋窝淋巴结转移预测因素的显著性。
较高的肿瘤体积与乳房体积比往往是乳腺癌患者腋窝淋巴结转移的显著预测因素。